Tomasello Shawn
Insider CIK 1617239 · PRNB Director · KITE Chief Commercial Officer · GMDA Director · DPLO Director · FDMT Director · URGN Director · TCRR Director · ALVR Director · CABA Director · ABEO Director · PCYC Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2026-06-17 | 2026-06-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | P Buy | 2026-01-21 | 2026-01-21 | 22,725 | $2.21 | $50.2K | 22,725 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2025-06-17 | 2025-06-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| CABA Cabaletta Bio, Inc. | A Award deriv | 2025-06-09 | 2025-06-09 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | A Award deriv | 2025-05-19 | 2025-05-19 | 44,000 | — | $0 | 44,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | D To issuer deriv | 2025-05-19 | 2025-05-19 | 22,000 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | A Award deriv | 2025-05-19 | 2025-05-19 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | D To issuer deriv | 2025-05-19 | 2025-05-19 | 44,000 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2024-06-06 | 2024-06-07 | 35,000 | — | $0 | 70,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | A Award deriv | 2024-06-03 | 2024-06-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2024-05-21 | 2024-05-23 | 22,500 | — | $0 | 22,500 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award | 2024-01-31 | 2024-02-02 | 200,000 | — | $0 | 241,977 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award deriv | 2023-10-19 | 2023-10-20 | 56,600 | — | $0 | 56,600 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award deriv | 2023-10-19 | 2023-10-20 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award | 2023-10-19 | 2023-10-20 | 28,300 | — | $0 | 41,977 | SEC↗ |
| CABA Cabaletta Bio, Inc. | A Award deriv | 2023-07-21 | 2023-07-24 | 44,000 | — | $0 | 44,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 15,191 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 4,177 | — | $0 | 0 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | A Award deriv | 2023-05-23 | 2023-05-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2023-05-11 | 2023-05-12 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award deriv | 2023-03-20 | 2023-03-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award deriv | 2023-02-08 | 2023-02-10 | 56,600 | — | $0 | 56,600 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award | 2023-02-08 | 2023-02-10 | 28,300 | — | $0 | 41,977 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award deriv | 2022-11-18 | 2022-11-22 | 9,500 | — | $0 | 9,500 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award | 2022-11-18 | 2022-11-22 | 2,000 | — | $0 | 13,677 | SEC↗ |
| GMDA Gamida Cell Ltd. | P Buy | 2022-09-30 | 2022-10-04 | 9,677 | $1.55 | $15.0K | 11,677 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2022-05-23 | 2022-05-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 27,500 | — | $0 | 27,500 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2022-03-29 | 2022-03-31 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-06-07 | 2021-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics | A Award deriv | 2021-05-17 | 2021-05-19 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-02-03 | 2021-02-04 | 4,177 | — | $0 | 4,177 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-02-03 | 2021-02-04 | 15,191 | — | $0 | 15,191 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 10,240 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 20,475 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-06-08 | 2020-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 10,240 | — | $0 | 10,240 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2020-05-20 | 2020-05-22 | 43,035 | — | $0 | 43,035 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award | 2020-05-20 | 2020-05-22 | 35,938 | — | $0 | 35,938 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | D To issuer | 2020-02-10 | 2020-02-10 | 33,259 | $4.00 | $133.0K | 0 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | U Tender | 2020-02-10 | 2020-02-10 | 11,278 | $4.00 | $45.1K | 33,259 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | S Sale | 2019-10-02 | 2019-10-04 | 859 | $4.84 | $4.2K | 44,537 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-08-29 | 2019-08-30 | 20,475 | — | $0 | 20,475 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-08-29 | 2019-08-30 | 10,240 | — | $0 | 10,240 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-08-29 | 2019-09-04 | 20,475 | — | $0 | 20,475 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | S Sale | 2019-06-04 | 2019-06-05 | 1,274 | $4.85 | $6.2K | 45,396 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2019-06-03 | 2019-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | A Award | 2019-06-03 | 2019-06-05 | 33,259 | — | $0 | 46,670 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | A Award | 2018-10-01 | 2018-10-03 | 2,275 | — | $0 | 13,411 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | S Sale | 2018-06-05 | 2018-06-05 | 1,680 | $24.27 | $40.8K | 11,136 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | A Award | 2018-06-01 | 2018-06-05 | 3,654 | — | $0 | 12,816 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 67,000 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 38,500 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 93,000 | $116.13 | $10.80M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | U Tender | 2017-10-03 | 2017-10-05 | 16,135 | $180.00 | $2.90M | 39,933 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 39,933 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | G Gift | 2017-09-25 | 2017-10-05 | 5,000 | — | $0 | 56,068 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-09-25 | 2017-09-27 | 4,500 | — | $0 | 65,271 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-09-25 | 2017-09-27 | 4,203 | $179.66 | $755.1K | 61,068 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | A Award | 2017-06-01 | 2017-06-05 | 4,722 | — | $0 | 9,162 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-12-22 | 2016-12-27 | 38,500 | — | $0 | 38,500 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2016-12-22 | 2016-12-27 | 10,600 | — | $0 | 60,235 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2016-12-20 | 2016-12-22 | 4,901 | $50.86 | $249.3K | 49,635 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | A Award | 2016-06-01 | 2016-06-02 | 1,483 | — | $0 | 4,440 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2015-12-17 | 2015-12-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2015-12-17 | 2015-12-21 | 44,000 | — | $0 | 54,000 | SEC↗ |
| DPLO Diplomat Pharmacy, Inc. | A Award | 2015-10-06 | 2015-10-09 | 2,957 | — | $0 | 2,957 | SEC↗ |
| PCYC PHARMACYCLICS INC | D To issuer deriv | 2015-05-26 | 2015-05-28 | 100,000 | — | $0 | 0 | SEC↗ |
| PCYC PHARMACYCLICS INC | U Tender | 2015-05-26 | 2015-05-28 | 32 | $261.25 | $8.4K | 0 | SEC↗ |
| PCYC PHARMACYCLICS INC | U Tender | 2015-05-26 | 2015-05-28 | 7,302 | $261.25 | $1.91M | 0 | SEC↗ |
| PCYC PHARMACYCLICS INC | U Tender | 2015-05-26 | 2015-05-28 | 109 | $261.25 | $28.5K | 0 | SEC↗ |
| PCYC PHARMACYCLICS INC | D To issuer | 2015-05-26 | 2015-05-28 | 50,000 | $261.25 | $13.06M | 7,302 | SEC↗ |
| PCYC PHARMACYCLICS INC | U Tender | 2015-05-26 | 2015-05-28 | 61 | $261.25 | $15.9K | 0 | SEC↗ |
| PCYC PHARMACYCLICS INC | D To issuer | 2014-11-19 | 2015-02-27 | 5,390 | $138.37 | $745.8K | 57,110 | SEC↗ |
| PCYC PHARMACYCLICS INC | D To issuer | 2014-11-19 | 2014-11-20 | 5,390 | $138.37 | $745.8K | 57,110 | SEC↗ |
| PCYC PHARMACYCLICS INC | A Award deriv | 2014-08-18 | 2014-08-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PCYC PHARMACYCLICS INC | A Award | 2014-08-18 | 2014-08-19 | 62,500 | — | $0 | 62,500 | SEC↗ |